Company Name : Adley Lab
Address : SCO- 915, 1st Floor, Nac Manimazra, Chandigarh – (India)
Tel No: 9316316312
Email : export.adley@gmail.com, varunbatray2k@gmail.com
Website : http://www.adleylab.com/
Company Profile
Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges cannot wait. That’s why we at Adley are committed to applying science and our resources to improve health and well-being at every stage of life. ADLEY is an integrated, research based, pharmaceutical company, producing a wide range of quality, affordable medicines, trusted by healthcare professionals and patients across geographies. ADLEY has a footprint in all states of India, and is gradually making a dent in the international market. We have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like cancer.
To ensure we can continue to deliver on our commitments to the patients, customers who rely on us, we are focused on improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of the people involved in health care decisions. Through working in partnership with everyone from patients to health care providers and managed care organizations to international bodies, our goal is to ensure that people everywhere have access to affordable treatments and quality health care.
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…